XML 40 R27.htm IDEA: XBRL DOCUMENT
v3.22.1

Stock Compensation Plan | 12 Months Ended
--- | ---
Dec. 31, 2021
Share-based Payment Arrangement [Abstract] |
Stock Compensation Plan | (18) Stock Compensation Plan The Company has a stock-based employee compensation plan which allows for the issuance of stock options and restricted common stock, the purpose of which is to provide additional incentive to certain officers, directors, and key employees by facilitating their purchase of a stock interest in the Company. Compensation expense related to prior awards is recognized on a straight line basis over the vesting period, which is typically four years. The stock-based compensation cost related to these awards was $323,000, $304,000 and $286,000 for the years ended December 31, 2021, 2020 and 2019, respectively. The Company recognized tax benefits of $113,000, $105,000, and $71,000 for the years ended December 31, 2021, 2020 and 2019, respectively. For stock options, the exercise price may not be less than 100% of the fair market value of the shares on the date of the grant, and no option shall be exercisable after the expiration of ten years from the grant date. In determining compensation cost, the Black-Scholes option-pricing model is used to estimate the fair value of options on date of grant. The Black-Scholes model is a closed-end model that uses the assumptions outlined below. Expected volatility is based on historical volatility of the Company’s stock. The Company uses historical exercise behavior and other qualitative factors to estimate the expected term of the options, which represents the period of time that the options granted are expected to be outstanding. The risk-free rate for the expected term is based on U.S. Treasury rates in effect at the time of grant. On May 20, 2015, our stockholders approved the 2015 Stock Incentive Plan which authorized the issuance of equity awards covering 351,775 shares of common stock, as adjusted for subsequent stock dividends. On August 1, 2019, the Compensation Committee awarded 3,954, shares of restricted common stock, as adjusted for subsequent stock dividends, and options to acquire 74,557 shares of common stock, as adjusted for subsequent stock dividends. The restricted stock awards vest ratably over one year and the value was based on a stock price of $20.25 per share on the date such shares were granted, as adjusted for subsequent stock dividends. The options vest ratably over four years. On August 1, 2020, the Compensation Committee awarded 19,128 shares of restricted common stock, as adjusted for subsequent stock dividends. The value of the 19,128 shares was based on a stock price of $18.69 on the date such shares were granted, as adjusted for subsequent stock dividends. On August 1, 2021, the Compensation Committee awarded 3,024 shares of restricted common stock, as adjusted for subsequent stock dividends and options to acquire 51,091 shares of common stock, as adjusted for subsequent stock dividends. The restricted stock awards vest ratably over one year and the value was based on a stock price of $26.43 per share on the date such shares were granted, as adjusted for subsequent stock dividends. The options vest ratably over four years. The fair value of the options granted were determined using the following weighted-average assumptions as of the grant date: Schedule of Fair Value of Options Assumed
|  | 2021 |  |  | 2020 |  |  | 2019 |
|  | Years ended December 31, |
|  | 2021 |  |  | 2020 |  |  | 2019 |
Risk-free interest rate |  |  | 1.00 | % |  |  | n/a |  |  |  | 1.77 | %
Expected term |  |  | 7 year |  |  |  | n/a |  |  |  | 7 year |
Expected stock price volatility |  |  | 28.51 | % |  |  | n/a |  |  |  | 26.06 | %
Dividend yield |  |  | 2.88 | % |  |  | n/a |  |  |  | 3.41 | %
A summary of option activity during 2021 is presented below: Schedule of Share-based Compensation, Stock Options, Activity
(Dollars in thousands, except per share amounts) |  |  |  |  |  |  |  |  |
|  | Weighted |  |  | Weighted |  |  |  |
|  |  |  |  | average |  |  | average |  |  |  |
|  |  |  |  | exercise |  |  | remaining |  |  | Aggregate |
|  |  |  |  | price |  |  | contractual |  |  | intrinsic |
|  | Shares |  |  | per share |  |  | term |  |  | value |
Outstanding at January 1, 2021 |  |  | 102,630 |  |  | $ | 21.26 |  |  |  | 7.3 years |  |  | $ | 202 |
Granted |  |  | 48,658 |  |  | $ | 27.75 |  |  |  |  |  |  |  |  |
Effect of 5% stock dividend |  |  | 7,059 |  |  |  |  |  |  |  |  |  |  |  |  |
Forfeited/expired |  |  | (3,964 | ) |  | $ | 15.62 |  |  |  |  |  |  |  |  |
Exercised |  |  | (6,172 | ) |  | $ | 10.78 |  |  |  |  |  |  |  |  |
Outstanding at December 31, 2021 |  |  | 148,211 |  |  | $ | 22.97 |  |  |  | 7.8 years |  |  | $ | 848 |
Exercisable at December 31, 2021 |  |  | 54,371 |  |  | $ | 21.85 |  |  |  | 6.4 years |  |  | $ | 372 |
Fully vested options at December 31, 2021 |  |  | 54,371 |  |  | $ | 21.85 |  |  |  | 6.4 years |  |  | $ | 372 |
Additional information about stock options exercised is presented below: Schedule of Stock Option Exercised Additional Information
|  | 2021 |  |  | 2020 |  |  | 2019 |
(Dollars in thousands) |  | Years ended December 31, |
|  | 2021 |  |  | 2020 |  |  | 2019 |
Intrinsic value of options exercised (on exercise date) |  | $ | 141 |  |  | $ | 430 |  |  | $ | 42 |
Cash received from options exercised |  |  | 22 |  |  |  | 42 |  |  |  | 36 |
Excess tax benefit realized from options exercised |  | $ | 21 |  |  | $ | 32 |  |  | $ | - |
As of December 31, 2021, there was $342,000 of total unrecognized compensation cost related to the 93,840 outstanding unvested options that will be recognized over the following periods: Schedule of Share-based Compensation Arrangements by Share-based Payment Award
Year |  | Amount |
(Dollars in thousands)
Year |  | Amount |
2022 |  | $ | 129 |
2023 |  |  | 104 |
2024 |  |  | 69 |
2025 |  |  | 40 |
Total |  | $ | 342 |
The fair value of restricted stock on the vesting date was $229,000, $202,000 and $150,000 during the years ended December 31, 2021, 2020 and 2019 respectively. A summary of nonvested restricted common stock activity during 2021 is presented below: Schedule of Nonvested Share Activity
|  | Shares |  |  | Weighted average grant date price per share |
Nonvested restricted common stock at January 1, 2021 |  |  | 22,125 |  |  | $ | 20.83 |
Granted |  |  | 2,880 |  |  | $ | 27.75 |
Vested |  |  | (8,453 | ) |  | $ | 27.07 |
Forfeited |  |  | - |  |  | $ | - |
Effect of 5% stock dividend |  |  | 827 |  |  |  |  |
Nonvested restricted common stock at December 31, 2021 |  |  | 17,379 |  |  | $ | 21.05 |
As of December 31, 2021, there was $237,000 of total unrecognized compensation cost related to the 17,379 outstanding nonvested restricted shares that will be recognized over the following periods: Schedule of Share-based Compensation Arrangements by Share-based Payment Award
Year |  | Amount |
(Dollars in thousands)
Year |  | Amount |
2022 |  | $ | 136 |
2023 |  |  | 64 |
2024 |  |  | 37 |
Total |  | $ | 237 |

X
- Definition The entire disclosure for share-based payment arrangement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -URI http://asc.fasb.org/topic&trid=2228938 + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration